India Strengthens AYUSH Push with Budget 2026

India has significantly expanded its focus on traditional medicine systems under the AYUSH umbrella, with the Union Budget 2026–27 allocating ₹4,408 crore to the Ministry of AYUSH—nearly doubling its funding over the past five years.
Finance Minister Nirmala Sitharaman also announced the establishment of three new All-India Institutes of Ayurveda. These institutes are expected to function on lines similar to All India Institute of Medical Sciences (AIIMS), combining patient care, education, and advanced research.
Additionally, funding for the National AYUSH Mission has been increased by 66%, with a focus on modernising dispensaries, integrating AYUSH clinics into government hospitals, and upgrading drug-testing laboratories.
Integrating Traditional Medicine into Mainstream Healthcare
These policy measures signal a shift from treating traditional medicine as an alternative system to integrating it within India’s broader healthcare ecosystem. The AYUSH framework—which includes Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homoeopathy—is being positioned as a complementary pillar alongside modern medicine.
The government’s approach aims to strengthen infrastructure, improve accessibility, and standardise practices across the sector.
India-EU Trade Deal Expands Global Opportunities
India’s recent Free Trade Agreement with the European Union further enhances the global prospects of AYUSH systems, particularly Ayurveda.
Under the agreement:
Indian AYUSH practitioners may offer services in EU countries that do not specifically regulate traditional medicine.
Indian companies can establish Ayurvedic clinics in Europe with greater policy stability.
There is potential for mutual recognition of safety certifications, reducing the need for repeated testing of approved products.
Together, these provisions open new international markets and create opportunities for the global expansion of Indian traditional medicine.
Global Expansion Brings Regulatory Challenges
While the policy push offers growth potential, it also introduces new challenges. As AYUSH systems enter international markets, they will face stringent regulatory frameworks governing safety, efficacy, and quality.
Experts highlight the need for regulatory harmonisation to ensure that AYUSH products and services meet global standards. Without this alignment, India risks legal challenges and reputational concerns in highly regulated markets like the EU.
Need for Scientific Validation and Transparency
A key concern is the gap between traditional claims and scientific evidence. For AYUSH systems to gain global credibility, experts stress the importance of rigorous, independent evaluation.
This includes:
Transparent clinical trials
Peer-reviewed research
Independent oversight, free from institutional conflicts of interest
Publication of both positive and negative findings
The current model, where some studies are funded or overseen by the same bodies promoting AYUSH, raises concerns about credibility. Strengthening independent research frameworks will be critical for long-term acceptance.
Coexistence of Traditional and Modern Medicine
The debate around AYUSH is not framed as a competition with modern medicine but as an opportunity for coexistence. Traditional systems like Ayurveda offer holistic frameworks that view health as a balance between body, environment, and lifestyle.
In contrast, modern biomedicine focuses on targeted interventions and specific disease mechanisms. Together, these approaches can complement each other, expanding how health and wellness are understood and treated.
Conclusion
India’s expanded investment in AYUSH and its integration into global trade frameworks mark a pivotal moment for traditional medicine. While the opportunity for growth is significant, long-term success will depend on aligning heritage with scientific rigor, transparency, and global regulatory standards.
The path forward lies in balancing tradition with evidence—ensuring that AYUSH systems can scale globally without compromising credibility.


